IDH3G and Parkinson disease: Here, we show that impaired expression of IDH3G and MDH2, resulting in reduced α-KG levels and upregulated fumarate levels, is an important manifestation of PD TCA cycle disorders and the metabolic basis for mitochondrial-driven PD pathogenesis.